Cargando…

GLP-1–oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) mice

AIMS/HYPOTHESIS: Oestrogens have previously been shown to exert beta cell protective, glucose-lowering effects in mouse models. Therefore, the recent development of a glucagon-like peptide-1 (GLP-1)–oestrogen conjugate, which targets oestrogen into cells expressing GLP-1 receptors, offers an opportu...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwenk, Robert W., Baumeier, Christian, Finan, Brian, Kluth, Oliver, Brauer, Christine, Joost, Hans-Georg, DiMarchi, Richard D., Tschöp, Matthias H., Schürmann, Annette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320309/
https://www.ncbi.nlm.nih.gov/pubmed/25527001
http://dx.doi.org/10.1007/s00125-014-3478-3
_version_ 1782356103969898496
author Schwenk, Robert W.
Baumeier, Christian
Finan, Brian
Kluth, Oliver
Brauer, Christine
Joost, Hans-Georg
DiMarchi, Richard D.
Tschöp, Matthias H.
Schürmann, Annette
author_facet Schwenk, Robert W.
Baumeier, Christian
Finan, Brian
Kluth, Oliver
Brauer, Christine
Joost, Hans-Georg
DiMarchi, Richard D.
Tschöp, Matthias H.
Schürmann, Annette
author_sort Schwenk, Robert W.
collection PubMed
description AIMS/HYPOTHESIS: Oestrogens have previously been shown to exert beta cell protective, glucose-lowering effects in mouse models. Therefore, the recent development of a glucagon-like peptide-1 (GLP-1)–oestrogen conjugate, which targets oestrogen into cells expressing GLP-1 receptors, offers an opportunity for a cell-specific and enhanced beta cell protection by oestrogen. The purpose of this study was to compare the effects of GLP-1 and GLP-1–oestrogen during beta cell failure under glucolipotoxic conditions. METHODS: Male New Zealand obese (NZO) mice were treated with daily s.c. injections of GLP-1 and GLP-1–oestrogen, respectively. Subsequently, the effects on energy homeostasis and beta cell integrity were measured. In order to clarify the targeting of GLP-1–oestrogen, transcription analyses of oestrogen-responsive genes in distinct tissues as well as microarray analyses in pancreatic islets were performed. RESULTS: In contrast to GLP-1, GLP-1–oestrogen significantly decreased food intake resulting in a substantial weight reduction, preserved normoglycaemia, increased glucose tolerance and enhanced beta cell protection. Analysis of hypothalamic mRNA profiles revealed elevated expression of Pomc and Leprb. In livers from GLP-1–oestrogen-treated mice, expression of lipogenic genes was attenuated and hepatic triacylglycerol levels were decreased. In pancreatic islets, GLP-1–oestrogen altered the mRNA expression to a pattern that was similar to that of diabetes-resistant NZO females. However, conventional oestrogen-responsive genes were not different, indicating rather indirect protection of pancreatic beta cells. CONCLUSIONS/INTERPRETATION: GLP-1–oestrogen efficiently protects NZO mice against carbohydrate-induced beta cell failure by attenuation of hyperphagia. In this regard, targeted delivery of oestrogen to the hypothalamus by far exceeds the anorexigenic capacity of GLP-1 alone. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-014-3478-3) contains peer-reviewed but unedited supplementary material, which is available to authorised users.
format Online
Article
Text
id pubmed-4320309
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-43203092015-02-11 GLP-1–oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) mice Schwenk, Robert W. Baumeier, Christian Finan, Brian Kluth, Oliver Brauer, Christine Joost, Hans-Georg DiMarchi, Richard D. Tschöp, Matthias H. Schürmann, Annette Diabetologia Article AIMS/HYPOTHESIS: Oestrogens have previously been shown to exert beta cell protective, glucose-lowering effects in mouse models. Therefore, the recent development of a glucagon-like peptide-1 (GLP-1)–oestrogen conjugate, which targets oestrogen into cells expressing GLP-1 receptors, offers an opportunity for a cell-specific and enhanced beta cell protection by oestrogen. The purpose of this study was to compare the effects of GLP-1 and GLP-1–oestrogen during beta cell failure under glucolipotoxic conditions. METHODS: Male New Zealand obese (NZO) mice were treated with daily s.c. injections of GLP-1 and GLP-1–oestrogen, respectively. Subsequently, the effects on energy homeostasis and beta cell integrity were measured. In order to clarify the targeting of GLP-1–oestrogen, transcription analyses of oestrogen-responsive genes in distinct tissues as well as microarray analyses in pancreatic islets were performed. RESULTS: In contrast to GLP-1, GLP-1–oestrogen significantly decreased food intake resulting in a substantial weight reduction, preserved normoglycaemia, increased glucose tolerance and enhanced beta cell protection. Analysis of hypothalamic mRNA profiles revealed elevated expression of Pomc and Leprb. In livers from GLP-1–oestrogen-treated mice, expression of lipogenic genes was attenuated and hepatic triacylglycerol levels were decreased. In pancreatic islets, GLP-1–oestrogen altered the mRNA expression to a pattern that was similar to that of diabetes-resistant NZO females. However, conventional oestrogen-responsive genes were not different, indicating rather indirect protection of pancreatic beta cells. CONCLUSIONS/INTERPRETATION: GLP-1–oestrogen efficiently protects NZO mice against carbohydrate-induced beta cell failure by attenuation of hyperphagia. In this regard, targeted delivery of oestrogen to the hypothalamus by far exceeds the anorexigenic capacity of GLP-1 alone. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-014-3478-3) contains peer-reviewed but unedited supplementary material, which is available to authorised users. Springer Berlin Heidelberg 2014-12-20 2015 /pmc/articles/PMC4320309/ /pubmed/25527001 http://dx.doi.org/10.1007/s00125-014-3478-3 Text en © The Author(s) 2014 https://creativecommons.org/licenses/by/4.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Article
Schwenk, Robert W.
Baumeier, Christian
Finan, Brian
Kluth, Oliver
Brauer, Christine
Joost, Hans-Georg
DiMarchi, Richard D.
Tschöp, Matthias H.
Schürmann, Annette
GLP-1–oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) mice
title GLP-1–oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) mice
title_full GLP-1–oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) mice
title_fullStr GLP-1–oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) mice
title_full_unstemmed GLP-1–oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) mice
title_short GLP-1–oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) mice
title_sort glp-1–oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone new zealand obese (nzo) mice
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320309/
https://www.ncbi.nlm.nih.gov/pubmed/25527001
http://dx.doi.org/10.1007/s00125-014-3478-3
work_keys_str_mv AT schwenkrobertw glp1oestrogenattenuateshyperphagiaandprotectsfrombetacellfailureindiabetespronenewzealandobesenzomice
AT baumeierchristian glp1oestrogenattenuateshyperphagiaandprotectsfrombetacellfailureindiabetespronenewzealandobesenzomice
AT finanbrian glp1oestrogenattenuateshyperphagiaandprotectsfrombetacellfailureindiabetespronenewzealandobesenzomice
AT klutholiver glp1oestrogenattenuateshyperphagiaandprotectsfrombetacellfailureindiabetespronenewzealandobesenzomice
AT brauerchristine glp1oestrogenattenuateshyperphagiaandprotectsfrombetacellfailureindiabetespronenewzealandobesenzomice
AT joosthansgeorg glp1oestrogenattenuateshyperphagiaandprotectsfrombetacellfailureindiabetespronenewzealandobesenzomice
AT dimarchirichardd glp1oestrogenattenuateshyperphagiaandprotectsfrombetacellfailureindiabetespronenewzealandobesenzomice
AT tschopmatthiash glp1oestrogenattenuateshyperphagiaandprotectsfrombetacellfailureindiabetespronenewzealandobesenzomice
AT schurmannannette glp1oestrogenattenuateshyperphagiaandprotectsfrombetacellfailureindiabetespronenewzealandobesenzomice